Mohamad I Harb

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Evidence on the use of fingolimod in real-world clinical practice and data on patient-reported health-related quality of life (HRQoL) in countries such as the Middle East are sparse. The(More)
Title: Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle(More)
  • 1